| Literature DB >> 34222691 |
Daniel Edem Kpewou1,2, Faustina O Mensah2, Collins A Appiah2, Huseini Wiisibie Alidu3, Vitus Sambo Badii4.
Abstract
Vitamin E is a potent antioxidant that helps to counteract oxidative stress in the body. Oxidative stress is known to greatly affect people living with HIV (PLWH) through the stimulation of HIV replication and apoptosis of CD4+ T cells. There is however, a paucity of scientific data on the serum levels of vitamin E among PLWH in Ghana, and hence, there is a need to assess its level because of the pivotal role it plays in cell longevity determination and the immune system enhancement of such persons. This study aims to assess the serum levels of vitamin E among PLWH undergoing highly active antiretroviral therapy at Ho Teaching Hospital, Ghana. In a cross-sectional study, serum vitamin E levels of 103 randomly selected PLWH aged 24-88 years who attended an antiretroviral therapy clinic at the Ho Teaching Hospital, Ghana, were measured by following standard protocols. A 24-hour dietary recall and food frequency questionnaire were employed to assess dietary intake. The results show that a high level of serum vitamin E deficiency (82.5%) was observed among the participants. Majority (91.3%) of the participants had normal serum zinc status. Participants' serum vitamin E levels did not show significant correlation with their dietary intakes (correlation coefficient (ρ) = -0.094, p-value = 0.35). The prevalence of vitamin E deficiency among underweight, normal weight, overweight, and obese participants was 91.7%, 75.4%, 86.5%, and 91.7% respectively with no significant difference among these groups. There was no significant correlation between serum vitamin E levels and HIV infection duration (ρ = 0.010, p-value = 0.405) and HAART duration (ρ = 0.001, p-value = 0.313). The low serum vitamin E levels found in this study suggests that the participants could potentially be at an increased risk of developing oxidative stress and its effects.Entities:
Keywords: Antioxidant; Antiretroviral drug; HIV; Micronutrient; Oxidative stress; Vitamin E
Year: 2021 PMID: 34222691 PMCID: PMC8243377 DOI: 10.1016/j.heliyon.2021.e07339
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Basic characteristics of study participants stratified by gender.
| Characteristic | Male (%) | Female (%) | Total (%) | |
|---|---|---|---|---|
| Less than 30 | 5 (19.2) | 7 (9.1) | 12 (11.6) | |
| between 30 and 40 | 2 (7.7) | 13 (16.9) | 15 (14.6) | |
| between 40 and 50 | 6 (23.1) | 28 (36.4) | 34 (33.0) | |
| between 50 and 60 | 9 (34.6) | 21 (27.3) | 30 (29.1) | |
| 60 and above | 4 (15.4) | 8 (10.4) | 12 (11.6) | |
| Married | 14 (53.8) | 32 (41.6) | 46 (44.7) | |
| Not married | 12 (46.6) | 45 (58.4) | 57 (55.3) | |
| No formal education | 2 (7.7) | 6 (7.8) | 8 (7.8) | |
| Basic | 17 (65.4) | 60 (77.9) | 77 (74.8) | |
| Secondary | 5 (19.2) | 8 (10.4) | 13 (12.6) | |
| Tertiary | 2 (7.7) | 3 (3.9) | 5 (4.9) | |
| Civil servant | 5 (19.2) | 4 (5.2) | 9 (8.7) | |
| Self-employed | 15 (57.7) | 69 (89.6) | 84 (81.6) | |
| Unemployed | 2 (7.7) | 4 (5.2) | 6 (5.8) | |
| Others | 4 (15.4) | 0 (0.0) | 4 (3.9) | |
| Ewe | 24 (92.3) | 73 (94.8) | 97 (94.2) | |
| Akan | 1 (3.8) | 3 (3.9) | 4 (3.9) | |
| Other | 1 (3.8) | 1 (1.3) | 2 (1.9) | |
| Less than 5 | 17 (65.4) | 44 (57.4) | 61 (59.2) | |
| Between 5 and 10 | 8 (30.8) | 30 (39.0) | 38 (36.9) | |
| 10 and above | 1 (3.8) | 3 (3.9) | 4 (3.9) | |
| Less than 5 | 18 (69.2) | 46 (59.7) | 64 (62.1) | |
| Between 5 and 10 | 7 (26.9) | 29 (37.7) | 36 (35.0) | |
| 10 and above | 1 (3.9) | 2 (2.6) | 3 (2.9) | |
Data are presented as absolute values with corresponding percentages in parentheses.
Serum vitamin E and serum zinc status of participants.
| Number of participants | Percentage | |
|---|---|---|
| Less than 12 μmol/L | 85 | 82.5 |
| Above 12 μmol/L | 18 | 17.5 |
| Total | 103 | 100.0 |
| 0–9.2 (μmoI/L) | 9 | 8.7 |
| 9.2–19.9 (μmoI/L) | 94 | 91.3 |
| Total | 103 | 100.0 |
Data are presented as absolute values (n) with corresponding percentages in parentheses. Serum zinc data -based on Johns Hopkins Medical Laboratories reference values (9.2–19.9 μmoI/L).
Body mass index distribution among participants.
| Underweight | Normal | Overweight | Obese | p – value | |
|---|---|---|---|---|---|
| % Vitamin E deficient | 91.7 | 75.4 | 86.4 | 91.7 | 0.22 |
| % Vitamin E sufficient | 8.3 | 24.6 | 13.6 | 8.3 |
Data is presented as percentages; n is the total number of participants in each category. P-value generated from a chi square test. P-value is significant at p < 0.05. Each column sums up to 100%.
Pattern of nutrients intake by participants by gender.
| Males | Females | |||||
|---|---|---|---|---|---|---|
| Nutrient intake | AMDR | P-value | Nutrient intake | AMDR | P-value | |
| Calories | 1956.5 (764.0–4314.0) | 1900.0 (1400.0–2400.0) | 0.47 | 1552.0 (384–4688) | 1700.0 (1300.0–2000.0) | 0.62 |
| Macronutrients | ||||||
| Carbohydrate(g) | 332.0 (130.0–777.0) | 260.0 (240.0–290.0) | 0.02 | 240.0 (76.9–836.0) | 225.0 (200.0–250.0) | 0.04 |
| Fat(g) | 33.40 (4.52–129.0) | 70.0 (65.0–76.0) | 0.02 | 37.9 (3.5–94.4) | 60.5 (56.0–65.0) | |
| Protein(g) | 70.25 (14.5–127.0) | 60.0 (49.0–72.0) | 0.15 | 46.1 (7.7–156) | 50.2 (42.0–62.0) | 0.80 |
| Micronutrients | ||||||
| Zinc (mg) | 9.4 (2.78–26.2) | 11.00 | 0.40 | 8.4 (1.7–28.1) | 8.0 | 0.30 |
| Vitamin A (μg) | 307.0 (15.5–3306) | 900.00 | 0.29 | 287.0 (0–3350) | 700.0 | 0.61 |
| Vitamin C (mg) | 43.9 (0–255) | 90.00 | 57.70 (0.00–334.0) | 75.0 | 0.38 | |
| Vitamin D (μg) | 0.0 (0–89.2) | 15.00 | < | 0.0 (0–72.7) | 15.0 | < |
| Vitamin E (mg) | 0.0 (0.00–6.97) | 15.00 | < | 0.0 (0.0–8.5) | 15.0 | < |
Data are presented as median with minimum and maximum values in parenthesis. AMDR – Acceptable Macro/Micro-nutrient Distribution Ranges/Values for adults (WHO, 2004). Carbohydrate, 50–60%; Fat, 30–35%; and Protein, 10–15% of total calorie for macronutrients. P-values were generated from Wilcoxon signed-rank test and were statistically significant at p < 0.05. Significant p-values are in bold.
Figure 1Participant consumption pattern of selected vitamins A, C, and E, and zinc-rich food.
Correlation between duration of HAART and HIV infection and serum zinc and vitamin E of participants.
| HAART duration | Duration of HIV infection | |||
|---|---|---|---|---|
| r2 | P-value | r2 | P-value | |
| Serum zinc (μmol/L) | 0.053 | 0.02∗ | 0.048 | 0.03∗ |
| Serum vitamin E (μmol/L) | 0.001 | 0.31 | 0.010 | 0.41 |
Data are presented as r2 (p-value). r2-coefficient of determination. ∗P-value is significant at p < 0.05.